A Non-Invasive Panel Of Serum Fibrosis Markers Can Reliably Differentiate Hepatitis C Patients With Minimal Fibrosis From Those With Fibrosis Stages F2-F4. K Patel,Sc Gordon,E Oh,K Smith,Jg MchutchisonHEPATOLOGY(2002)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要